Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.1029040
Abstract: Background The availability of biosimilar medicines in Southern European markets has allowed purchasing biologics at a lower cost for healthcare systems. However, the capacity to seize this cost-reduction opportunity in the long run depends on…
read more here.
Keywords:
italy portugal;
portugal spain;
tnf alpha;